AntidilutiveNotes1 [Member] Antidilutive Securities [Axis] AntidilutiveNotes2 [Member] AntidilutiveNotes3 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Senior Note1 [Member] Related Party [Axis] Senior Note 2 [Member] Senior Note 3 [Member] Senior Note 4 [Member] Senior Note 5 [Member] Senior Notes Total [Member] SeniorNoteNonCurrent [Member] Seven% Note [Member] Seven % Current [Member] SevenPercentNoncurrent [Member] BurrPilgerMayer [Member] Desjardins [Member] McCarthyTetrault [Member] M F Note A [Member] M F Note B [Member] UniversityHealthNote1 [Member] Service Provider Notes Total [Member] Service Providers After Discount [Member] Service Providers Current [Member] Service Providers Noncurrent [Member] Insurance Company [Member] Vendor [Member] Vendor Current [Member] Unrelated Parties [Member] Unrelated Parties Current [Member] Unrelated Parties Noncurrent [Member] Cato Note 1 [Member] Cato Note 2 [Member] Related Parties Aggregate [Member] Related Parties After Discount [Member] Related Parties Current [Member] Related Parties Noncurrent [Member] ConvertibleNoteJuly [Member] Senior Note Total [Member] Unit Notes [Member] Unit Notes 2 [Member] Ten % Total [Member] Ten % Convertible [Member] MF Note A [Member] MF Note B [Member] Univ Health Note [Member] Service Providers Total [Member] Service Note Current [Member] Service Notes Noncurrent [Member] SevenPercentNote[Member] SevenPercentCurrent [Member] Private Placement 2014 [Member] Schedule Of Equity Method Investment Equity Method Investee Name [Axis] Minimum [Member] Range [Axis] Maximum [Member] Amendment Warrants [Member] Equity Securities by Investment Objective [Axis] Adjustment M&F [Member] Class of Warrant or Right [Axis] Adjustment CRL [Member] Adjustment UHN [Member] Pre-Modification [Member] Short-term Debt, Type [Axis] Post-Modification [Member] Warrant 1 [Member] Warrant 2 [Member] Warrant 3 [Member] Warrant 4 [Member] Warrant 5 [Member] Warrant 6 [Member] Warrant 7 [Member] Warrant 8 [Member] Warrant 9 [Member] Warrant 10 [Member] Autilion AG [Member] 2013 Private Placement [Member] Technology License [Member] Consulting Agreement for Services [Member] Officer [Member] CBV Note [Member] CRL Note [Member] Platinum Warrants [Member] Securities Financing Transaction [Axis] Platinum Stock Units [Member] Platinum Note Units [Member] C B V Note [Member] July Platinum [Member] Securities Financing [Axis] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Prepaid expenses and other current assets Total current assets Property and equipment, net Security deposits and other assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable Accrued expenses Advance from officer Current portion of notes payable and accrued interest Current portion of notes payable to related parties and accrued interest Convertible promissory notes and accrued interest, net of discount of $1,251,000 and $697,400 at September 30, 2014 and March 31, 2014, respectively Capital lease obligations Total current liabilities Non-current liabilities: Senior secured convertible promissory notes, net of discount of 0 at September 30, 2014 and $2,085,900 at Marchi 31, 2014 and accrued interest Notes payable, net of discount of $672,700 at September 30, 2014 and $848,100 at March 31, 2014 and Notes payable to related parties, net of discount of $79,600 at September 30, 2014 and $103,200 at March 31, 2014 and accrued interest Warrant liability Deferred rent liability Capital lease obligations Total non-current liabilities Total liabilities Commitments and contingencies Stockholders' deficit: Preferred stock, $0.001 par value; 10,000,000 shares, including 500,000 Series A shares, authorized at September 30, 2014 and March 31, 2014; 500,000 Series A shares issued and outstanding at September 30, 2014 and March 31, 2014 Common stock, $0.001 par value; 10,000,000 shares authorized at September 30, 2014 and March 31, 2014; 1,421,343 and 1,310,093 shares issued at September 30, 2014 and March 31, 2014, respectively Additional paid-in capital Treasury stock, at cost, 135,665 shares of common stock held at September 30, 2014 and March 31, 2014 Notes receivable from sale of common stock Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Convertible promissory notes and accrued interest, net of discount Senior secured convertible promissory notes, net of discount Notes payable, net of discount Notes payable to related parties, net of discount Stockholders deficit: Preferred Stock, par value Preferred Stock, Authorized PreferredStockSeriesASharesIssued PreferredStockSeriesASharesOutstanding Common Stock, Par Value Par Share Common Stock, Shares Authorized Common Stock, Shares, Issued Treasury Stock, Shares Income Statement [Abstract] Revenue Operating expenses: Research and development General and administrative Total operating expenses Loss from operations Other expenses, net: Interest expense, net Change in warrant liability Loss on extinguishment of debt Loss before income taxes Income taxes Net income (loss) Basic net loss per share: Diluted net loss per share: Weighted average shares used in computing basic net loss attributable to common stockholders per common share Weighted average shares used in computing diluted net loss attributable to common stockholders per common share Comprehensive income (loss) Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Amortization of discounts on convertible and promissory notes Change in warrant liability Stock-based compensation Expense related to modification of warrants Non-cash rent and relocation expense Interest income on note receivable for stock purchase Fair value of common stock granted for services Fair value of warrants granted for services and interest Gain on currency fluctuation Loss on extinguishment of debt Changes in operating assets and liabilities: Prepaid expenses and other current assets Security deposits and other assets Accounts payable and accrued expenses, including accrued interest Net cash used in operating activities Cash flows from investing activities: Purchases of equipment, net Net cash used in investing activities Cash flows from financing activities: Net proceeds from issuance of common stock and warrants, including Units Proceeds from exercise of modified warrants Proceeds from sale of note and warrant to Platinum Advance from officer Repayment of capital lease obligations Repayment of notes Net cash provided by financing activities Net (decrease) increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Notes to Financial Statements NOTE 1 - History and Organization NOTE 2 - Basis of Presentation and Going Concern NOTE 3 - Summary of Significant Accounting Policies NOTE 4 - Fair Value Measurements NOTE 5 - Prepaid Expenses and Other Current Assets NOTE 6 - Accrued Expenses NOTE 7 - Convertible Promissory Notes and Other Notes Payable NOTE 8 - Capital Stock NOTE 9 - Related Party Transactions NOTE 10 - Subsequent Events Summary Of Significant Accounting Policies Policies Basis of Presentation and Going Concern Use of Estimates Revenue Recognition Research and Development Expenses Stock-Based Compensation Warrant Liability Comprehensive Loss Loss per Common Share Recent Accounting Pronouncements Summary Of Significant Accounting Policies Tables Summary of stock-based compensation expense Basic and diluted net loss attributable to common stockholders per share Schedule of antidilutive securities excluded from computation of earnings per share Fair Value Measurements Tables Fair value heirarchy for liabilities measured at fair value on a recurring basis Changes in Level 3 liabilities Prepaid Expenses And Other Current Assets Tables Prepaid Expenses Accrued Expenses Tables Accrued Expenses Convertible Promissory Notes And Other Notes Payable Tables Convertible Promissory Notes and Other Notes Payable Capital Stock Tables Unit Warrant grants and allocation of Proceeds Black-Scholes Option Pricing Model Description of units Description Of Business Details Narrative NIH awarded the Company aggregate support Merger shares Basis Of Presentation And Going Concern Details Narrative Accumulated Deficit Cash proceeds from convertible and short-term notes Cash proceeds from grant awards and other events Cash proceeds from Autilion purchase agreement Equity issuance Cash expenditure Share purchase obligation Share purchase obligation cash consideration initial share issuance Note interest rate Debt issued Warrant exercise price Private placement proceeds Alternative financing, minimum Summary Of Significant Accounting Policies Details Research and development expense: Stock option grants, including expense related to modifications Warrants granted to officer in March 2014 and 2013 Total research and development expense related to stock-based compensation expense General and administrative expense: Stock option grants, including expense related to modifications Warrants granted to officers and directors in March 2014 and 2013 Total General and administrative expense related to stock-based compensation expense Total stock-based compensation expense Summary Of Significant Accounting Policies Details 1 Numerator: Net loss attributable to common stockholders for basic earnings per share less: change in fair value of warrant liability attributable to Exchange, Investment and Bridge Warrants issued to Platinum Net loss for diluted earnings per share attributable to common stockholders Denominator: Weighted average basic common shares outstanding Assumed conversion of dilutive securities: Warrants to purchase common stock Potentially dilutive common shares assumed converted Denominator for diluted earnings per share - adjusted weighted average shares: Denominator for diluted earnings per share - adjusted weighted average shares Basic net loss per share: Net loss Diluted net loss per share: Net loss Statement [Table] Statement [Line Items] Loss per Common Share Series A preferred stock issued and outstanding Warrant shares issuable to Platinum upon exercise of common stock warrants by Platinum upon exchange of Series A preferred stock under the terms of the October 11, 2012 Note Exchang and Purchase Agreement Outstanding options under the 2008 and 1999 Stock Incentive Plans Outstanding warrants to purchase common stock Convertible promissory notes and accrued interest Total Summary Of Significant Accounting Policies Details Narrative Granted options to purchase common stock Exercise price of granted options to purchase common stock Exercise price of granted options to purchase common stock, Maximum Options outstanding to purchase Common stock Weighted average exercise price of outstanding options Liabilities, Fair Value Disclosure Warrant liability Warrant liability, beginning of period Mark to Market gain included in net income Warrant liability, end of period Prepaid Expenses And Other Current Assets Details Prepaid Expenses Insurance Costs associated with Public Offering Legal fees Interest receivable on note receivable from sale of common stock Technology license fees and all other Total Accrued Expenses Details Accrued Expenses Accrued professional services Accrued compensation All other Total Principal Balance Accrued Interest Total Note discount on principal Note discount on accrued interest Note discount, total Investment, Name [Axis] SecuritiesFinancingAxis [Axis] Investment Warrant exercise price Restricted common stock Units sold Cash proceeds from exercise of warrants Qualified financing Effective interest rate Weighted average interest rate Amended warrants Amended warrants value Fair value warrant Exercise price per share Repayment of warrants, value Change in warrant put and note extension option and warrant liabilities Non-cash charge to loss on extinguishment of debt Reduction to the loss on extinguishment of debt Net amount of loss on extinguishment of debt Fair value of additional warrant shares Conversion of notes Fair value of senior notes Accrued interest on note Beneficial conversion feature amount Warrant shares issued Weighted Average Issuance Date Valuation Assumptions Market price per share Exercise price per share Expected term (years) Risk-free interest rate Volatility Dividend rate Fair Value per share Aggregate fair value of unit warrants Aggregate proceeds of unit sales Aggregate allocation of proceeds based on relative fair value of unit Warrants outstanding Exercise price per share Expirate date range Weighted average years to expiration Shares subject to purchase Purchase obligation Initial closing of financing Initial issuance of shares under puchase agreement Initial face amount Stem cell technology license maintenance fees Repayment of previous advances to officers Exercise price Placement Units Exercise price at grant date Fair value of stock Market price per share Average payments for professional services Cash proceeds Loss on early extinguishment of debt License and maintenance fees, added to note payable Short-term cash advances from executive officer Investment in lieu of cash repayment Repayment of cash advances Proceeds from short-term loan Interest rate on note Total interest expense Incurred expenses on research and subsequent other projects Promissory note issuance Subsequent Events Details Narrative Shares issued Exercise price 2014 Unit Notes aggregate face amount Cash payment from note receivable Repayment of principal balance of note Blackscholes Option Pricing Model Table Text Block. Custom Element. Custom Element Custom Element Desjardins Member. Custom Element Custom Element Custom Element Legal Fees1. Custom Element. Custom Element. Custom Element Custom Element Custom Element Notes Payable Discount. Notes Payable Discount Related Parties. Custom Element Outstanding Shares. Outstanding Warrants To Purchase Common Stock. Custom element. Custom element. Custom Element Custom Element Custom Element Custom Element Prepaid Expenses TableText Block. Custom Element Custom Element Custom Element Custom Element. Total. Unrelated Parties Member. Warrant exercise price. Assets, Current Assets Liabilities, Current Capital Lease Obligations, Noncurrent Liabilities, Noncurrent Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest ChangeInPutAndNoteTermExtensionOptionAndWarrantLiabilities Gains (Losses) on Recourse Debt Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Deposit Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Machinery and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Long-term Capital Lease Obligations Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, at Carrying Value RelatedToStockOptionGrantsIncludingExpenserelatedToModifications Earnings Per Share, Basic [Abstract] Earnings Per Share, Diluted [Abstract] Earnings Per Share [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Prepaid Expense, Current [Abstract] Prepaid Expense and Other Assets, Current Accrued Liabilities, Current [Abstract] Long-term Debt, Gross Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Share Price